Punnya V Angadi1, Sanjay S Rao. 1. Department of Oral and Maxillofacial Pathology and Microbiology, KLEVK Institute of Dental Sciences and Hospital, Belgaum, Karnataka, India. punnya_angadi@rediffmail.com
Abstract
BACKGROUND: Oral submucous fibrosis is a disease due to a chronic, insidious change in fibro-elasticity, characterized by burning sensation in the oral cavity, blanching, and stiffening of the oral mucosa and oropharynx leading to trismus and inability to open the mouth. The symptoms and signs depend on the progression of the lesions and number of affected sites. It is predominantly seen in Indians and other Asians. Once the disease has developed, there is neither regression nor any effective treatment. It is considered as a pre-malignant stage of oral cancer, and the reported risk of malignant transformation varies from 2.3-7.6%. CONCLUSIONS: The common etiological factor considered for this unremitting disease is use of areca nut; however, the precise mechanism still remains elusive and controversial. A wide range of treatment consisting of drugs, surgical therapy, and physiotherapy have been attempted till date, with varying degrees of benefit, but none of them have proved to be a cure for this disease. This field remains open for clinical trials and research. This paper aims to give an overview on the role of areca nut in the pathogenesis and malignant potential of oral submucous fibrosis.
BACKGROUND: Oral submucous fibrosis is a disease due to a chronic, insidious change in fibro-elasticity, characterized by burning sensation in the oral cavity, blanching, and stiffening of the oral mucosa and oropharynx leading to trismus and inability to open the mouth. The symptoms and signs depend on the progression of the lesions and number of affected sites. It is predominantly seen in Indians and other Asians. Once the disease has developed, there is neither regression nor any effective treatment. It is considered as a pre-malignant stage of oral cancer, and the reported risk of malignant transformation varies from 2.3-7.6%. CONCLUSIONS: The common etiological factor considered for this unremitting disease is use of areca nut; however, the precise mechanism still remains elusive and controversial. A wide range of treatment consisting of drugs, surgical therapy, and physiotherapy have been attempted till date, with varying degrees of benefit, but none of them have proved to be a cure for this disease. This field remains open for clinical trials and research. This paper aims to give an overview on the role of areca nut in the pathogenesis and malignant potential of oral submucous fibrosis.
Authors: P C Gupta; F S Mehta; D K Daftary; J J Pindborg; R B Bhonsle; P N Jalnawalla; P N Sinor; V K Pitkar; P R Murti; R R Irani; H T Shah; P M Kadam; K S Iyer; H M Iyer; A K Hegde; G K Chandrashekar; B C Shiroff; B E Sahiar; M N Mehta Journal: Community Dent Oral Epidemiol Date: 1980 Impact factor: 3.383
Authors: P N Sinor; P C Gupta; P R Murti; R B Bhonsle; D K Daftary; F S Mehta; J J Pindborg Journal: J Oral Pathol Med Date: 1990-02 Impact factor: 4.253
Authors: W M Tilakaratne; Z Iqbal; M T Teh; A Ariyawardana; G Pitiyage; A Cruchley; J E Stewart; E Hagi-Pavli; A Lalli; A Waseem; E K Parkinson; F Fortune Journal: J Oral Pathol Med Date: 2008-01-19 Impact factor: 4.253